Moneyta · stock research · no sign-up needed
ZTS
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q2 FY2026)
$2.5B
+12.3% y/y
Net income (Q2 FY2026)
$691M
as filed with the SEC
Institutions holding
1,441
-182 last quarter
Overview · Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectiv…
Management team
- Mr. Nick Ashton · Executive VP and President of Global Manufacturing & SupplyFind on LinkedIn
- Ms. Jeannette Ferran Astorga · Executive VP of Corporate Affairs & Communications and Chief Sustainability OfficerFind on LinkedIn
- Dr. Robert J. Polzer Ph.D. · Executive VP and President of Research & DevelopmentFind on LinkedIn
- Mr. Steven Frank · Vice President of Investor RelationsFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on ZTS
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.